Address

Pappas Ventures
Research Triangle Park
PO Box 110287
NC 27709
United States

Open map


Recent investment activity

Tags
KANDO id: 3260

Corporate information

Also known as
Pappas Capital
Registration country

Funding rounds

Top investment portfolio themes

Actual initial investment stage
N/A (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 63
Profile Country Date Funding
Arena Pharmaceuticals Inc N/A
ArgoMed N/A
BaroSense Inc A medical device company N/A
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. N/A
BioSyntech A medical device company N/A
Bloodhound Technologies Medical claims processing software company. N/A
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. N/A
Calyx Therapeutics N/A
CeNeRx BioPharma Inc A specialty biopharmaceutical company N/A
Cequent Pharmaceuticals N/A
Cerexa Inc N/A
Chimerix Inc Series F
Cognetix Biopharmaceutical company that developed peptide therapeutics for the treatment of epilepsy, pain and anesthesia. N/A
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. N/A
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. Series B
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. Series A
Dynogen Pharmaceuticals Inc Drug company focused on gastrointestinal and genitourinary disorders. N/A
EBM Solutions N/A
Elitra Phramaceuticals Antimicrobial functional genomics company N/A
Emerald BioAgriculture Corp Bioagriculture company developing, manufacturing and marketing biological and biochemical agents. N/A
Exelixis Inc N/A
FlowCardia Inc A medical device company commercializing products for the treatment of chronic total occlusions (CTOs) of coronary and peripheral arteries. N/A
Gentis Inc Developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine. N/A
LEAD Therapeutics A chemistry-driven small-molecule drug discovery company N/A
Liquidia Technologies Inc N/A

Past employees

Selected Products / Customers

Financials